Search research articles
Contact Us
Filters
Showing results (101-110 of 138) with videos related to
Page
of 14
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 10, 1998
Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II study
T D Nguyen, S Theobald, P Rougier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 1996
Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study
D J Wagener, W J Hoogenraad, P Rougier, et al.
Journal of the American Chemical Society
|
September 16, 2021
Accessing Photoredox Transformations with an Iron(III) Photosensitizer and Green Light
Akin Aydogan, Rachel E Bangle, Alejandro Cadranel, et al.
Bulletin Du Cancer
|
January 17, 2002
[Standards, options and recommendations for tumor markers in colorectal cancer]
N Eche, M F Pichon, V Quillien, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 30, 2004
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer
J M Blazeby, T Conroy, A Bottomley, et al.
British Journal of Cancer
|
October 14, 2010
Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
T Conroy, Y Yataghène, P L Etienne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 10, 2011
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab
D Malka, V Boige, N Jacques, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2002
Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients
J-F Seitz, J Bennouna, B Paillot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 22, 2009
Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer
R N Whistance, T Conroy, W Chie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series
J Y Blay, T Conroy, C Chevreau, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 138) with videos related to
Sort By:
Page
of 14
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 10, 1998
Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II study
T D Nguyen, S Theobald, P Rougier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 1996
Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study
D J Wagener, W J Hoogenraad, P Rougier, et al.
Journal of the American Chemical Society
|
September 16, 2021
Accessing Photoredox Transformations with an Iron(III) Photosensitizer and Green Light
Akin Aydogan, Rachel E Bangle, Alejandro Cadranel, et al.
Bulletin Du Cancer
|
January 17, 2002
[Standards, options and recommendations for tumor markers in colorectal cancer]
N Eche, M F Pichon, V Quillien, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 30, 2004
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer
J M Blazeby, T Conroy, A Bottomley, et al.
British Journal of Cancer
|
October 14, 2010
Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
T Conroy, Y Yataghène, P L Etienne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 10, 2011
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab
D Malka, V Boige, N Jacques, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2002
Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients
J-F Seitz, J Bennouna, B Paillot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 22, 2009
Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer
R N Whistance, T Conroy, W Chie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series
J Y Blay, T Conroy, C Chevreau, et al.
Page
of 14